NMNAT2 Antibody (FITC)
This NMNAT2 Antibody, FITC conjugated is an FITC polyclonal product. It tagets NMNAT2 using a Recombinant Human Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 protein (1-153AA) as the immunogen. Purification: >95%, Protein G purified.
Product Specifications
Product Name Alternative
C1orf15 antibody; KIAA0479 antibody; MGC2756 antibody; NaMN adenylyltransferase 2 antibody; Nicotinamide mononucleotide adenylyltransferase 2 antibody; Nicotinamide nucleotide adenylyltransferase 2 antibody; Nicotinate-nucleotide adenylyltransferase 2 antibody; NMN adenylyltransferase 2 antibody; NMNA2_HUMAN antibody; NMNAT 2 antibody; Nmnat2 antibody; PNAT 2 antibody; PNAT2 antibody; Pyridine nucleotide adenylyltransferase 2 antibody
UniProt
Q9BZQ4
Reactivity
Human
Immunogen
Recombinant Human Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 protein (1-153AA)
Target
NMNAT2
Clonality
Polyclonal
Conjugation
FITC
Field of Research
Signal Transduction
Purification
>95%, Protein G purified
Dilution
ELISA
Form
Liquid
Storage Conditions
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
For research use only.
Host or Source
Rabbit
Preservative
Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol
Isotype
IgG
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB0637-100 1x 100 µL
Renal Cell Carcinoma (Carbonic Anhydrase IX) (PN-15), 0.2mg/mL
Sign In for Pricing
View Details 
ICH5079-10mg 10 mg (2x 5 mg)
Sabatolimab Biosimilar - Research Grade
Sign In for Pricing
View Details 
BNC402171-100 1x 100 µL
Human Kappa Light Chain (B-Cell Marker) (rKLC264), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 